Please login to the form below
Prosonix
This page shows the latest Prosonix news and features for those working in and with pharma, biotech and healthcare.
Circassia slumps as cat allergy vaccine fails late-stage trial
drugs and novel combinations gained through its acquisitions of Aerocrine and Prosonix last year.
Latest news
-
Allergy specialist Circassia buys asthma firms
Circassia will pay £139m ($219m) for Aerocrine and up to £100m for Prosonix. ... fit. “Prosonix has near-term products that help us create an allergy-asthma specialist pharmaceutical company.”.
More from news
Approximately 1 fully matching, plus 1 partially matching documents found.
Latest Intelligence
-
Pharma deals in May 2015
155. Prosonix/Circassia. Corporate acquisition. Portfolio of generic respiratory products includingfluticasone. 152.
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
- Roche to acquire Carmot Therapeutics in deal worth up to $3.1bn
- Eli Lilly’s Jaypirca granted FDA accelerated approval for non-Hodgkin lymphomas
- UK-India research project trialling easy-to-use UTI test to support fight against AMR
- Cancer Research UK and Guardant collaborate to advance cancer detection and treatment
- Give the gift of positive change
- Apple Vision Pro: challenges and opportunities for pharma
No results were found
PMHub
Redbow Consulting Group
Redbow Consulting Group is a specialist healthcare management consultancy specialising in business strategy and marketing...
Latest intelligence
- New Playbook Alert: Virtual Patient Engagement
- ...
- Millennials: the wellness generation
- Looking at the results from a global healthcare research study focusing on the patients of the future...
- The problem with clinical trials (and how virtual insight-gathering can help)
- While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....
